Omamah Alfarisi

Research Associate

20172018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
rifapentine Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Pyrazinamide Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Latent Tuberculosis Medicine & Life Sciences
Diabetes Mellitus Medicine & Life Sciences
Isoniazid Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2018

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment

Alfarisi, O., Mave, V., Gaikwad, S., Sahasrabudhe, T., Ramachandran, G., Kumar, H., Gupte, N., Kulkarni, V., Deshmukh, S., Atre, S., Raskar, S., Lokhande, R., Barthwal, M., Kakrani, A., Chon, S., Gupta, A., Golub, J. E. & Dooley, K. E., Nov 1 2018, In : Antimicrobial agents and chemotherapy. 62, 11

Research output: Contribution to journalArticle

Pyrazinamide
Diabetes Mellitus
Tuberculosis
Pharmacokinetics
Isoniazid

Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?

Alfarisi, O., Alghamdi, W. A., Al-Shaer, M. H., Dooley, K. E. & Peloquin, C. A., Aug 19 2017, (Accepted/In press) In : Expert Review of Clinical Pharmacology. p. 1-10 10 p.

Research output: Contribution to journalArticle

rifapentine
Rifampin
Latent Tuberculosis
Tuberculosis
Drug Interactions